Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Current Deferred Revenue (2016 - 2022)

Amn Healthcare Services (AMN) has disclosed Current Deferred Revenue for 14 consecutive years, with $11.3 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Current Deferred Revenue fell 4.41% year-over-year to $11.3 million, compared with a TTM value of $11.3 million through Dec 2023, down 4.41%, and an annual FY2023 reading of $11.3 million, down 4.41% over the prior year.
  • Current Deferred Revenue was $11.3 million for Q4 2023 at Amn Healthcare Services, down from $13.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $17.9 million in Q3 2021 and bottomed at $11.0 million in Q4 2020.
  • Average Current Deferred Revenue over 5 years is $13.6 million, with a median of $13.2 million recorded in 2020.
  • The sharpest move saw Current Deferred Revenue surged 50.45% in 2021, then decreased 25.86% in 2022.
  • Year by year, Current Deferred Revenue stood at $11.8 million in 2019, then fell by 6.65% to $11.0 million in 2020, then soared by 44.95% to $16.0 million in 2021, then decreased by 25.86% to $11.8 million in 2022, then dropped by 4.41% to $11.3 million in 2023.
  • Business Quant data shows Current Deferred Revenue for AMN at $11.3 million in Q4 2023, $13.9 million in Q1 2023, and $11.8 million in Q4 2022.